Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Rigshospitalet orders new Novalis Tx radiosurgery platforms non-invasive radiosurgery

Varian : 24 July, 2008  (Application Story)
One of Scandinavia's leading cancer centres has ordered three Novalis Tx radiosurgery platforms which combine the most advanced technologies from Varian Medical Systems and BrainLAB to offer non-invasive radiosurgery for patients.
Rigshospitalet in Copenhagen, Denmark, has ordered two new Novalis Tx Radiosurgery platforms and the associated suite of accessories and will upgrade an existing BrainLAB Novalis device to the more advanced new generation Novalis Tx. All three machines will be equipped with Varian's RapidArc Radiotherapy technology for image-guided, intensity-modulated Radiotherapy (IMRT) treatments, meaning seven treatment machines at the hospital will have this new capability. They will also include the BrainLAB ExacTrac X-ray 6D imaging system and the Varian On-Board Imager for precise patient positioning.

Dr Svend Aage Engelholm, chief radiation oncologist of the Department of Radiation Oncology at Copenhagen University Hospital (Rigshospitalet), said, 'The two new Novalis Tx platforms will mainly be used for state-of-the-art lung and prostate cancer treatments while most of the other extra-cranial stereotactic treatments will take place on the upgraded device.'

Dr Engelholm added that Rigshospitalet has a long tradition of carrying out high-precision Radiotherapy treatments and is one of the two leading hospitals in Denmark for stereotactic radiosurgery. The hospital was the first in Scandinavia to introduce IMRT treatments and was also the region's first hospital to offer image-guided Radiotherapy (IGRT) as a routine preferred treatment for a number of cancer indications.

Novalis Tx offers Radiosurgery for a wide range of indications such as malignant and benign lesions, brain metastases, arteriovascular malformations, and functional lesions. The system features high dose delivery rates, which means that treatments can be delivered rapidly. Novalis Tx also offers dynamic fine beam shaping and non-invasive, precise frameless patient positioning for rapid and comfortable treatments.

Novalis Tx allows multiple beam energies of up to 18 million volts for treating deep-seated tumours.

'The speed coupled with the precise beam shaping and advanced imaging capabilities make advanced radiosurgical treatments with Novalis Tx more affordable for hospitals and their patients,' added Dow Wilson, head of Varian's Oncology Systems business.

The Novalis Tx platform also includes an On-Board Imager device for pinpointing the tumour and positioning the patient with millimetre precision. The platform's ExacTrac room-based image-guidance system provides continual imaging during treatment to detect movement and support robotic adjustments in patient positioning in six dimensions. This enhances protection of surrounding healthy tissues while enabling clinicians to concentrate higher, more effective doses on tumours.

Jean Hooks, general manager oncology solutions at BrainLAB, added, 'Novalis Tx offers extensive imaging capabilities with three complementary imaging systems. These are representative of the power our partnership with Varian brings to the field of radiosurgery. Novalis Tx answers strong demand from the clinical community for a fast, versatile, precise instrument that offers new hope to many cancer patients.'

The latest investment at Rigshospitalet is part of a Denmark-wide strategy to ensure cancer patients receive their first Radiotherapy treatment within four weeks of diagnosis. According to Dr Engelholm, his hospital is on course to ensure most patients receive advanced Radiotherapy treatment within two weeks of diagnosis.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo